Vaccine Manufacturing Articles - BioPharm International


Vaccine Manufacturing Articles

FDA Licenses First US Facility for Cell-Culture Influenza Vaccines

June 16, 2014

Novartis facility becomes the first US site licensed by the FDA to produce cell-culture influenza vaccines.

Regulatory Requirements for Viral-Challenge Studies: Influenza Case Study

May 1, 2014

Review regulatory requirements and the use of viral-challenge studies in drug development.

Novel Vaccine Technologies Meet the Need for Pandemic and Therapeutic Solutions

May 1, 2014

New approaches to vaccine production are targeting rapid supply for pandemic situations and broadly effective therapeutic treatments.

FDA Details National Vaccine Plan

March 11, 2014

HHS plan makes progress in ensuring availability of safe vaccines.

European Medicines Agency Updates Seasonal Flu Vaccine Guidance

February 11, 2014

EMA releases an update on its flu vaccine guidance.

EMA Launches Vaccine Monitoring Project

November 26, 2013

European Medicines Agency announces the launch of the Accelerated development of vaccine benefit-risk collaboration in Europe (ADVANCE) project.

PhRMA Report Shows New Vaccine Development

October 4, 2013

PhRMA report reflects robust R&D in vaccine development.

Bioprocessing Advances in Vaccine Manufacture

August 1, 2013

Advances in techniques and single-use systems are revolutionizing vaccine manufacturing.

Discovery Pipeline: Improved Delivery of RNA Vaccines

November 1, 2012

Creating an effective nucleic acid-based vaccine requires protecting the fragile nucleic acid from degradation, effective transfection of the targeted cells, and producing high enough levels of antigen to evoke a robust immune response.



Click here